|
 | alexandrossfakianakis shared this article with you from Inoreader | |
|
| | | | During the past 15 years, public health systems have had to face two huge challenges, the global financial and the COVID-19 pandemic crises. The way European governments have dealt with these crises has been diverse. Austerity measures were applied during the financial crisis, whereas maintaining investment or even boosting public spending was the governments' response during the COVID-19 crisis. Recently, it has been well established that fiscal austerity increases the prevalence of multimorbidity and worsens the health-related quality of life,1 although the impact on excess mortality is less clear.2,3 In contrast, the COVID-19 crisis resulted in a cumulative excess of deaths worldwide4 and increased stress on health systems. However, the impact these tensions and divergent policies have had on a specific and demanding disease such as Glioblastoma is as yet unknown. | |
|
| View on Web |
|
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου